Observational studyHepatology (Baltimore, Md.)2022
Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice.
Jingjing Duan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
68 papers cite itlatest 60 shown
this paperpooled itcites it